2型糖尿病早期糖尿病多发性神经病变与心血管疾病发病率升高相关:两项丹麦队列研究结果
本研究链接丹麦ADDITION-Denmark和DD2两个2型糖尿病队列与全国健康登记数据,用密歇根神经病变筛查量表问卷(MNSIq)评估糖尿病多发性神经病变(DPN),MNSIq≥4视为提示DPN。采用泊松回归计算心血管疾病(CVD)和全因死亡的发病率比(IRR)。结果显示MNSIq≥4与CVD发病率升高相关,合并IRR为1.65(95%CI 1.41-1.95),但与死亡率无关。
要点
- MNSIq≥4提示的DPN与2型糖尿病早期CVD发病率升高独立相关。
- 合并分析CVD的IRR为1.65(95%CI 1.41-1.95),校正传统CVD危险因素后仍显著。
- MNSIq≥4与全因死亡无显著关联,合并死亡率比为1.11(95%CI 0.83-1.48)。
核心结论
- MNSIq评分≥4提示的DPN与2型糖尿病早期CVD发病率显著升高相关,且独立于已确立的CVD危险因素。
- MNSIq可能有助于识别新诊断2型糖尿病中CVD高发的亚组人群。
研究设计与样本
- 链接ADDITION-Denmark和DD2两个丹麦2型糖尿病队列与全国健康登记数据。
- ADDITION-Denmark在诊断糖尿病时完成MNSIq,DD2在诊断后中位4.6年完成MNSIq。
- MNSIq评分≥4视为提示DPN,采用泊松回归计算CVD和全因死亡的IRR,并校正多种已确立CVD危险因素。
- 纳入ADDITION-Denmark 1,445人、DD2 5,028人。
主要发现
- 与MNSIq<4相比,MNSIq≥4者CVD的IRR在ADDITION-Denmark为1.79(95%CI 1.38-2.31),在DD2为1.57(95%CI 1.27-1.94)。
- 固定效应荟萃分析合并CVD的IRR为1.65(95%CI 1.41-1.95)。
- MNSIq≥4与死亡率无显著关联,合并死亡率比为1.11(95%CI 0.83-1.48)。
关键数值与推荐
- MNSIq评分≥4定义为提示DPN。
- CVD合并IRR为1.65(95%CI 1.41-1.95)。
- 全因死亡合并死亡率比为1.11(95%CI 0.83-1.48)。
临床怎么用
- 对新诊断2型糖尿病患者可考虑使用MNSIq筛查DPN,以识别CVD高发风险亚组。
- MNSIq≥4提示DPN时,应加强CVD风险评估与管理,即使传统危险因素已控制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Symptoms indicative of diabetic polyneuropathy (DPN) early in type 2 diabetes may act as a marker for cardiovascular disease (CVD) and death. RESEARCH DESIGN AND METHODS: We linked data from two Danish type 2 diabetes cohorts, the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Denmark) and the Danish Centre for Strategic Research in Type 2 Diabetes (DD2), to national health care registers. The Michigan Neuropathy Screening Instrument questionnaire (MNSIq) was completed at diabetes diagnosis in ADDITION-Denmark and at a median of 4.6 years after diagnosis of diabetes in DD2. An MNSIq score ≥4 was considered as indicative of DPN. Using Poisson regressions, we computed incidence rate ratios (IRRs) of CVD and all-cause mortality comparing MNSIq scores ≥4 with scores <4. Analyses were adjusted for a range of established CVD risk factors. RESULTS: In total, 1,445 (ADDITION-Denmark) and 5,028 (DD2) individuals were included in the study. Compared with MNSIq scores <4, MNSIq scores ≥4 were associated with higher incidence rate of CVD, with IRRs of 1.79 (95% CI 1.38-2.31) in ADDITION-Denmark, 1.57 (CI 1.27-1.94) in the DD2, and a combined IRR of 1.65 (CI 1.41-1.95) in a fixed-effect meta-analysis. MNSIq scores ≥4 did not associate with mortality; combined mortality rate ratio was 1.11 (CI 0.83-1.48). CONCLUSIONS: The MNSIq may be a tool to identify a subgroup within individuals with newly diagnosed type 2 diabetes with a high incidence rate of subsequent CVD. MNSIq scores ≥4, indicating DPN, were associated with a markedly higher incidence rate of CVD, beyond that conferred by established CVD risk factors.
引用
- Bjerg L, Nicolaisen SK, Christensen DH, et al. Diabetic Polyneuropathy Early in Type 2 Diabetes Is Associated With Higher Incidence Rate of Cardiovascular Disease: Results From Two Danish Cohort Studies. Diabetes Care. 2021. PMID: 34039686. doi:10.2337/dc21-0010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。